75% of the net proceeds from The Susan G. Komen Central Valley Race for the Cure® stays in the local community to fund breast health education, breast cancer screening and treatment projects.
The remaining 25% of the net proceeds supports the national Komen for the Cure Grant Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.
Brief Summary of Priorities
Drawing from outcome-based information from the Komen Central Valley Community Profile, and other local and national studies, the Central Valley Affiliate of Susan G. Komen® has identified the following priorities for its 2013/2014 Community Grants Program:
Drawing from the profile, the Central Valley Affiliate has identified the following funding priority areas:
1. Projects focusing on screening for all underserved/underinsured.
2. Projects focusing on culturally appropriate breast health education, screening, treatment or support services for the following underserved groups: African American women, Hispanic women, Asian/Pacific Islander women, Middle-Eastern women, Native American women, young women in their teens and twenties, women who partner with women, women with disabilities, and monolingual women. These projects should focus on production and distribution of culturally and linguistically appropriate breast health education materials.
3. Projects focusing on culturally appropriate support services for breast cancer survivors, especially those focusing on underserved women identified above, as well as focusing on needs of breast cancer survivors that are not covered by medical insurance- lymphedema treatment, prostheses, cosmetic needs, etc.
2011 Community Profile for Download
The Community Profile is a needs assessment document that provides an overview of Komen’s grant-making priorities and the breast health needs in our service area. Please familiarize yourself with this document before developing your applications. Download 2011 Komen Central Valley Community Profile